RXRX is expected to provide updates on its oncology and rare disease clinical-stage pipeline in its first-quarter 2025 earnings release, given the absence of a marketed product.

Recursion Pharmaceuticals, Inc.’s RXRX share price has surged by 7.02%, which has investors questioning if this is right time ...

North Carolina woman Hannah-Ireland Durando recently claimed that Taylor Swift's music made her aware of having symptoms of ...

随着影像学技术的进步，尤其是量子相位显像（QSM）的方法不断被引入，科学家们正在探索海绵状血管畸形的发病机制，并寻找新的风险评估和个体化治疗策略。在2025年即将举办的中国脑血管病论坛上，业内顶尖的专家将聚焦海绵状血管畸形的研究热点，深入探讨手术技术的细分、前沿影像评估手段及其分子机制等问题，或许将为这类疾病的治疗带来新的曙光。

Last month, Markovic revealed she was undergoing surgery for an arteriovenous malformation - an abnormal tangle of blood vessels that looks like a bird’s nest. Last month, Markovic revealed she was ...

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...

Although her family did not share Markovic's cause of death, the model shared via Instagram in March that she needed surgery to treat an arteriovenous malformation (AVM) "the size of a golf ball ...

Recursion Pharmaceuticals RXRX announced that it has dosed the first patient in its early-stage study of investigational candidate, REC-3565, for treating relapsed or refractory (R/R) B-cell lymphomas ...

Recursion Pharmaceuticals is developing its lead candidate, REC-994, for treating cerebral cavernous malformation (CCM), a neurovascular condition that impacts approximately 360,000 symptomatic ...

1 Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China 2 Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical ...